drug · small molecule
patient view →NTO-1151
Phase 3updated 2mo agoby Resilience Government Services Inc🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 11 investigational indications.
targets
Ribonucleotide reductase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that